These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33023325)

  • 1. Contemporary Review of Antithrombotic Therapy in Peripheral Artery Disease.
    Hess CN; Bonaca MP
    Circ Cardiovasc Interv; 2020 Oct; 13(10):e009584. PubMed ID: 33023325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of vorapaxar on cardiovascular and limb outcomes in patients with peripheral artery disease with and without coronary artery disease: Analysis from the TRA 2°P-TIMI 50 trial.
    Qamar A; Morrow DA; Creager MA; Scirica BM; Olin JW; Beckman JA; Murphy SA; Bonaca MP
    Vasc Med; 2020 Apr; 25(2):124-132. PubMed ID: 32000630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cohort Study Examining the Association of Immunosuppressant Drug Prescription With Major Adverse Cardiovascular and Limb Events in Patients With Peripheral Artery Disease.
    Golledge J; Velu R; Quigley F; Jenkins J; Singh TP
    Ann Vasc Surg; 2022 Jan; 78():310-320. PubMed ID: 34537348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases.
    Savarese G; Reiner MF; Uijl A; D'Amario D; Agewall S; Atar D; Baumgartner I; Borghi C; De Carlo M; Drexel H; Kaski JC; Kjeldsen KP; Kucher N; Lund LH; Niessner A; Semb AG; Schmidt TA; Sulzgruber P; Tamargo J; Vitale C; Wassmann S; Aboyans V; Lewis BS
    Eur Heart J Cardiovasc Pharmacother; 2020 Apr; 6(2):86-93. PubMed ID: 31392312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic treatment in peripheral artery disease.
    Olinic DM; Tataru DA; Homorodean C; Spinu M; Olinic M
    Vasa; 2018 Feb; 47(2):99-108. PubMed ID: 29160765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary Medical Management of Peripheral Artery Disease.
    Bonaca MP; Hamburg NM; Creager MA
    Circ Res; 2021 Jun; 128(12):1868-1884. PubMed ID: 34110910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin use improves limb salvage after intervention for peripheral arterial disease.
    Parmar GM; Novak Z; Spangler E; Patterson M; Passman MA; Beck AW; Pearce BJ
    J Vasc Surg; 2019 Aug; 70(2):539-546. PubMed ID: 30718113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of Major Atherothrombotic Vascular Events among Patients with Peripheral Artery Disease after Revascularization.
    Desai U; Kharat A; Hess CN; Milentijevic D; Laliberté F; Zuckerman P; Benson J; Lefebvre P; Hiatt WR; Bonaca MP
    Ann Vasc Surg; 2021 Aug; 75():217-226. PubMed ID: 33819600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic Treatments in Patients with Chronic Coronary Artery Disease or Peripheral Artery Disease: A Systematic Review of Randomised Controlled Trials.
    Bauersachs R; Wu O; Briere JB; Bowrin K; Borkowska K; Jakubowska A; Taieb V; Toumi M; Huelsebeck M
    Cardiovasc Ther; 2020; 2020():3057168. PubMed ID: 32695228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotics in stable peripheral artery disease.
    Kaplovitch E; Rannelli L; Anand SS
    Vasc Med; 2019 Apr; 24(2):132-140. PubMed ID: 30799766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic kidney disease and outcomes of lower extremity revascularization for peripheral artery disease.
    Smilowitz NR; Bhandari N; Berger JS
    Atherosclerosis; 2020 Mar; 297():149-156. PubMed ID: 31948675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk).
    Bonaca MP; Nault P; Giugliano RP; Keech AC; Pineda AL; Kanevsky E; Kuder J; Murphy SA; Jukema JW; Lewis BS; Tokgozoglu L; Somaratne R; Sever PS; Pedersen TR; Sabatine MS
    Circulation; 2018 Jan; 137(4):338-350. PubMed ID: 29133605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Literature review and meta-analysis of the efficacy of cilostazol on limb salvage rates after infrainguinal endovascular and open revascularization.
    Desai K; Han B; Kuziez L; Yan Y; Zayed MA
    J Vasc Surg; 2021 Feb; 73(2):711-721.e3. PubMed ID: 32891809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial disparities in outcomes of endovascular procedures for peripheral arterial disease: an evaluation of California hospitals, 2005-2009.
    Loja MN; Brunson A; Li CS; Carson JG; White RH; Romano PS; Hedayati N
    Ann Vasc Surg; 2015 Jul; 29(5):950-9. PubMed ID: 25757991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of dual-antiplatelet therapy durations after endovascular revascularization of infrainguinal arteries.
    Sarode K; Mohammad A; Das S; Vinas A; Banerjee A; Tsai S; Armstrong EJ; Shammas NW; Klein A; Brilakis ES; Banerjee S
    Ann Vasc Surg; 2015 Aug; 29(6):1235-44. PubMed ID: 26026491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins and Major Adverse Limb Events in Patients with Peripheral Artery Disease: A Systematic Review and Meta-Analysis.
    Pastori D; Farcomeni A; Milanese A; Del Sole F; Menichelli D; Hiatt WR; Violi F
    Thromb Haemost; 2020 May; 120(5):866-875. PubMed ID: 32369857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral Artery Disease Leading to Major Amputation: Trends in Revascularization and Mortality Over 18 Years.
    Abry L; Weiss S; Makaloski V; Haynes AG; Schmidli J; Wyss TR
    Ann Vasc Surg; 2022 Jan; 78():295-301. PubMed ID: 34182110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study.
    Mohammedi K; Woodward M; Hirakawa Y; Zoungas S; Colagiuri S; Hamet P; Harrap S; Poulter N; Matthews DR; Marre M; Chalmers J;
    Cardiovasc Diabetol; 2016 Sep; 15(1):129. PubMed ID: 27590190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic Literature Review of Randomized Trials Comparing Antithrombotic Therapy Following Revascularization Procedures in Patients With Peripheral Artery Disease.
    Schindewolf M; Beyer-Westendorf J; Balradj J; Bowrin K; Huelsebeck M; Briere JB
    Angiology; 2020 Oct; 71(9):773-790. PubMed ID: 32638610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic therapy in peripheral artery disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
    Alonso-Coello P; Bellmunt S; McGorrian C; Anand SS; Guzman R; Criqui MH; Akl EA; Vandvik PO; Lansberg MG; Guyatt GH; Spencer FA
    Chest; 2012 Feb; 141(2 Suppl):e669S-e690S. PubMed ID: 22315275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.